Investigating TCF4's role in Pitt-Hopkins syndrome
TCF4 in Pitt-Hopkins syndrome
This study is looking for ways to help people with Pitt-Hopkins syndrome by finding new treatments that can boost a gene important for brain function, which could improve their speech and overall development.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10680426 on NIH RePORTER |
What this research studies
This research focuses on Pitt-Hopkins syndrome (PTHS), a neurodevelopmental disorder that leads to significant challenges such as loss of speech, seizures, and severe intellectual disabilities. The study aims to explore ways to enhance the expression of the TCF4 gene, which is crucial for normal brain function and is deficient in individuals with PTHS. By using small molecules to potentially increase TCF4 levels, the researchers hope to develop effective treatments that address the core symptoms of this disorder. The project includes assessing how TCF4 is distributed in the body and testing different strategies to normalize its expression during critical developmental periods.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Pitt-Hopkins syndrome, particularly those experiencing its core symptoms.
Not a fit: Patients without a diagnosis of Pitt-Hopkins syndrome or those who do not exhibit the core symptoms of the disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve the quality of life for individuals with Pitt-Hopkins syndrome.
How similar studies have performed: While research on TCF4 and its role in PTHS is ongoing, this approach of targeting gene expression for treatment is innovative and has not been extensively tested in this context.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Philpot, Benjamin D — Univ of North Carolina Chapel Hill
- Study coordinator: Philpot, Benjamin D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.